EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Gut Microbial Metabolite Indole-3-Acetic Acid Reprograms Systemic Homeostasis and Ameliorates IBD-Associated Cachexia Independent of Food Intake

Ayame Tomii, Chihiro Takei, Keisuke Yoshikiyo iD, Hidehisa Shimizu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ayame Tomii und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Natural Science and Technology, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan. Hauptthemen laut MEDLINE: Indoleacetic Acids, Homeostasis, Cachexia, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is associated with severe systemic complications, including cachexia, anemia, and renal dysfunction, which represent a significant unmet medical need. The gut microbial metabolite indole-3-acetic acid (IAA) is known to be reduced in IBD; however, its therapeutic potential remains unclear. This study aimed to determine whether oral supplementation with IAA could ameliorate intestinal inflammation and its associated systemic complications. Using a dextran sulfate sodium (DSS)-induced colitis mouse model, we administered oral IAA and evaluated a comprehensive panel of clinical, metabolic, renal, and hematological parameters. Systemic health status was assessed using Principal Component Analysis (PCA). IAA administration significantly ameliorated DSS-induced colitis, reducing the Disease Activity Index (DAI) (3.88 vs. 3.13; p < 0.05) and significantly attenuating colon shortening (5.0 cm vs. 5.78 cm; p < 0.05) compared to the DSS-alone group. Crucially, it markedly suppressed systemic complications: IAA ameliorated DSS-induced cachexia (ΔBody weight, −3.27 g vs. −1.83 g; p < 0.05), an effect independent of food intake (N.S.). Furthermore, IAA mitigated early-stage renal dysfunction, as evidenced by a significant reduction in plasma Creatinine (Cr) levels (0.12 mg/dL vs. 0.10 mg/dL; p = 0.05), and reversed the decline in plasma iron levels associated with anemia (45.75 μg/dL vs. 63.50 μg/dL; p < 0.05). PCA revealed that IAA induced a distinct recovery profile, significantly improving the systemic health index without fully restoring the original homeostatic state. Oral IAA exerts pleiotropic effects on both intestinal inflammation and systemic complications. Its food intake-independent anti-cachectic mechanism represents a novel therapeutic paradigm for IBD-associated wasting. These findings position IAA as a promising candidate for microbial metabolite-based therapy aimed at reprogramming, rather than merely restoring, systemic homeostasis in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoleacetic AcidsHomeostasisCachexiaGastrointestinal MicrobiomeInflammatory Bowel DiseasesEatingAnimalsMiceMaleDisease Models, AnimalDextran SulfateColitisMice, Inbred C57BL

Stichwörter der Autor:innen

anemia of inflammationcachexiagut microbiotagut–kidney axismicrobial metaboliteprincipal component analysissystemic complications

Substanzen

Indoleacetic Acidsindoleacetic acidDextran Sulfate

Autor:innen und Institutionen

  • Graduate School of Natural Science and Technology, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan.
  • Faculty of Life and Environmental Sciences, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan.
  • The United Graduate School of Agricultural Sciences, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Tottori, Japan.
  • Institute of Agricultural and Life Sciences, Academic Assembly, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan.
  • Estuary Research Center, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan.
  • Interdisciplinary Center for Science Research, Shimane University, 1060 Nishikawatsu-Cho, Matsue 690-8504, Shimane, Japan.

ORCID-Profile: Keisuke Yoshikiyo, Hidehisa Shimizu

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Grants-in-Aid for Scientific Research

Zitieren

APA

Tomii, A., Takei, C., Yoshikiyo, K., & Shimizu, H. (2025). The Gut Microbial Metabolite Indole-3-Acetic Acid Reprograms Systemic Homeostasis and Ameliorates IBD-Associated Cachexia Independent of Food Intake. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311260

Vancouver

Tomii A, Takei C, Yoshikiyo K, Shimizu H. The Gut Microbial Metabolite Indole-3-Acetic Acid Reprograms Systemic Homeostasis and Ameliorates IBD-Associated Cachexia Independent of Food Intake. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311260

BibTeX
@article{Tomii2025,
  author = {Tomii, Ayame and Takei, Chihiro and Yoshikiyo, Keisuke and Shimizu, Hidehisa},
  title = {The Gut Microbial Metabolite Indole-3-Acetic Acid Reprograms Systemic Homeostasis and Ameliorates IBD-Associated Cachexia Independent of Food Intake},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311260}
}
Kostenlos starten →